President's Message
News Release
May 23, 2022
|
NEW
Announcement of exclusive license agreement for development, manufacturing and sale of glycerol phenylbutyrate in Japan
October 06, 2021
|
Updated President's Message and Corporate Profile
July 27, 2021
|
Press Release
Grifols and OrphanPacific start commercializing Lynspad™ [alpha-1 proteinase inhibitor] to treat alpha-1 antitrypsin deficiency
February 22, 2021
|
[IPM(Innovative Pharma Model) Introduction Video] CMIC Group Released "Creative Service to Support Drug Development Journey in Japan" Video
January 22, 2021
|
Press Release
Announcement of Japan’s regulator approves Grifols’ Lynspad™ [alpha1-proteinase inhibitor] for the treatment of alpha-1 antitrypsin deficiency
We associate with the activities of Rare Disease Day JAPAN and support activities.
